Observational studyArthritis research & therapy2026
Association between physical activity and all-cause mortality in rheumatoid arthritis: evidence from NHANES and UK Biobank cohort studies.
Observational study in Arthritis research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
importanceRheumatoid arthritis (RA), a chronic autoimmune disease linked to higher mortality, benefits from physical activity (PA), which has been shown to reduce disease activity and improve physical function. However, PA’s association with all-cause mortality in RA patients remains unclear.
objectiveTo investigate the relationship between various levels of PA and all-cause mortality among patients with RA. DESIGN, SETTING, AND
participantsThis dual-cohort observational study used data from the National Health and Nutrition Examination Survey (NHANES) from 2007 to 2018 and the UK Biobank database. PA was assessed using self-reported questionnaires in NHANES and 7-day wrist-worn accelerometers in the UK Biobank. MAIN OUTCOMES AND MEASURES: Cox proportional-hazards models and restricted cubic spline (RCS) analysis were employed to evaluate the association between PA and all-cause mortality. Subgroup and interaction analyses were conducted to examine the robustness of the findings. Stratified analyses were performed using polygenic risk scores for RA in the UK Biobank cohort. An analysis combining results from both cohorts was conducted using random-effects models to estimate pooled associations and assess heterogeneity.
resultsA total of 1493 patients with RA from the NHANES cohort and 1724 from the UK Biobank cohort were included. Across both cohorts, PA was significantly associated with a lower risk of all-cause mortality. In fully adjusted models, active and highly active groups showed reduced mortality risks compared with the inactive group [NHANES: hazard ratio (HR): active = 0.381, highly active = 0.675; UK Biobank: HR: active = 0.557, highly active = 0.491]. RCS analysis revealed a U-shaped association between PA and mortality in the NHANES cohort, with moderate PA levels showing the greatest protective effect. However, an L-shaped pattern was observed in the UK Biobank cohort, where the highly active group had the lowest mortality risk. A joint analysis in NHANES revealed that active work-related PA combined with inactive recreational PA yielded the greatest mortality reduction. In the UK Biobank, moderate-to-vigorous PA remained protective even among patients with high genetic risk. A pooled analysis combining both cohorts confirmed a robust inverse association between PA and all-cause mortality (HR: active = 0.48, highly active = 0.61), with low heterogeneity across studies. CONCLUSIONS AND RELEVANCE: PA is associated with reduced all-cause mortality in patients with RA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.